Patents by Inventor Naiying WU

Naiying WU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF PYRIDO[1,2-A]PYRIMIDINONE COMPOUND IN TREATING PERIPHERAL T CELL LYMPHOMA
    Publication number: 20230321104
    Abstract: A pyrido[1,2-a]pyrimidinone compound or a pharmaceutical composition thereof for treating peripheral T cell lymphoma, and a method for or use of a pyrido[1,2-a]pyrimidinone compound for treating peripheral T cell lymphoma.
    Type: Application
    Filed: September 15, 2021
    Publication date: October 12, 2023
    Inventors: Fan FENG, Xunqiang WANG, Ying ZHAO, XI HAN, Li CHEN, Ruiting MA, Naiying WU
  • COMBINED PHARMACEUTICAL COMPOSITION OF C-MET KINASE INHIBITOR AND ANTI-PD-L1 ANTIBODY
    Publication number: 20230263795
    Abstract: Provided are a combined pharmaceutical composition of an anti-PD-L1 antibody and a c-Met kinase inhibitor, specifically, a combined pharmaceutical composition of an anti-PD-L1 antibody and N-(4-((7-((1-(cyclopentylamino)cyclopropyl)methoxy)-6-methoxyquinolin-4-yl)oxy)-3-fluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and the use of the combined pharmaceutical composition in the treatment of cancers, in particular, gastric cancer or liver cancer.
    Type: Application
    Filed: June 1, 2021
    Publication date: August 24, 2023
    Inventors: Xiquan ZHANG, Xunqiang Wang, Ding Yu, Tao LIU, Xiaole ZHAN, Naiying WU
  • USE OF PYRIDO[1,2-A]PYRIMIDINONE COMPOUND IN TREATING LYMPHOMA
    Publication number: 20230132982
    Abstract: The present application belongs to the field of medicinal chemistry, and relates to a use of a pyrido[1,2-a]pyrimidinone compound in treating lymphoma. Specifically, the present application relates to a pyrido[1,2-a]pyrimidinone compound or a pharmaceutical composition thereof for treating lymphoma, and a method or use of pyrido[1,2-a]pyrimidinone compound in treating lymphoma.
    Type: Application
    Filed: February 10, 2021
    Publication date: May 4, 2023
    Inventors: Fan FENG, Xunqiang WANG, Li CHEN, Xi HAN, Naiying WU, Ruiting MA, Chaoqiang YANG